Theratechnologies Historical Cash Flow

THTX Stock  USD 3.15  0.01  0.32%   
Analysis of Theratechnologies cash flow over time is an excellent tool to project Theratechnologies future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 10.7 M or Capital Expenditures of 1.8 M as it is a great indicator of Theratechnologies ability to facilitate future growth, repay debt on time or pay out dividends.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Theratechnologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Theratechnologies is a good buy for the upcoming year.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.

About Theratechnologies Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Theratechnologies balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Theratechnologies's non-liquid assets can be easily converted into cash.

Theratechnologies Cash Flow Chart

At this time, Theratechnologies' Net Borrowings is fairly stable compared to the past year. Change To Operating Activities is likely to rise to about 8.2 M in 2025, despite the fact that Change In Cash is likely to grow to (15.6 M).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most accounts from Theratechnologies' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Theratechnologies current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.At this time, Theratechnologies' Net Borrowings is fairly stable compared to the past year. Change To Operating Activities is likely to rise to about 8.2 M in 2025, despite the fact that Change In Cash is likely to grow to (15.6 M).

Theratechnologies cash flow statement Correlations

-0.02-0.64-0.01-0.53-0.44-0.040.440.080.470.13-0.39-0.08-0.320.49-0.31-0.390.37
-0.020.03-0.540.280.120.74-0.080.03-0.240.320.05-0.47-0.310.230.26-0.12-0.01
-0.640.030.430.810.77-0.210.37-0.01-0.34-0.530.79-0.060.30.160.60.63-0.49
-0.01-0.540.430.250.23-0.820.56-0.020.26-0.390.450.020.130.160.060.56-0.08
-0.530.280.810.250.49-0.080.220.11-0.4-0.270.82-0.190.110.20.620.66-0.44
-0.440.120.770.230.49-0.040.38-0.03-0.16-0.370.450.090.190.080.480.32-0.36
-0.040.74-0.21-0.82-0.08-0.04-0.36-0.34-0.60.21-0.41-0.13-0.170.01-0.15-0.60.05
0.44-0.080.370.560.220.38-0.360.060.21-0.470.37-0.13-0.020.690.240.29-0.1
0.080.03-0.01-0.020.11-0.03-0.340.060.610.050.39-0.250.260.130.670.23-0.5
0.47-0.24-0.340.26-0.4-0.16-0.60.210.610.260.01-0.09-0.090.050.140.180.17
0.130.32-0.53-0.39-0.27-0.370.21-0.470.050.26-0.43-0.2-0.35-0.31-0.26-0.080.65
-0.390.050.790.450.820.45-0.410.370.390.01-0.43-0.220.250.370.830.71-0.55
-0.08-0.47-0.060.02-0.190.09-0.13-0.13-0.25-0.09-0.2-0.220.11-0.56-0.33-0.090.08
-0.32-0.310.30.130.110.19-0.17-0.020.26-0.09-0.350.250.11-0.130.34-0.13-0.54
0.490.230.160.160.20.080.010.690.130.05-0.310.37-0.56-0.130.390.01-0.16
-0.310.260.60.060.620.48-0.150.240.670.14-0.260.83-0.330.340.390.44-0.66
-0.39-0.120.630.560.660.32-0.60.290.230.18-0.080.71-0.09-0.130.010.44-0.08
0.37-0.01-0.49-0.08-0.44-0.360.05-0.1-0.50.170.65-0.550.08-0.54-0.16-0.66-0.08
Click cells to compare fundamentals

Theratechnologies Account Relationship Matchups

Theratechnologies cash flow statement Accounts

202020212022202320242025 (projected)
Change In Cash7.7M3.5M10.2M(18.2M)(16.4M)(15.6M)
Free Cash Flow(14.6M)(15.7M)(7.5M)879K1.0M1.1M
Begin Period Cash Flow12.7M20.4M23.9M34.1M39.2M41.2M
Total Cashflows From Investing Activities(12.5M)8.7M1.1M942K1.1M1.1M
Other Cashflows From Financing Activities(7.5M)(4.0M)(2.5M)(5.4M)(4.9M)(4.6M)
Depreciation8.7M12.5M3.3M2.8M3.2M3.1M
Other Non Cash Items5.7M2.7M4.2M8.9M10.2M10.7M
Capital Expenditures166K985K1.8M1.5M1.7M1.8M
Total Cash From Operating Activities(14.5M)(14.7M)(5.7M)2.4M2.7M2.9M
Net Income(31.7M)(47.2M)(24.0M)(8.3M)(7.5M)(7.8M)
Total Cash From Financing Activities34.6M9.7M14.8M(21.5M)(19.3M)(18.4M)
End Period Cash Flow20.4M23.9M34.1M15.9M18.3M9.6M
Other Cashflows From Investing Activities(211K)9.7M(1.6M)59K53.1K55.8K
Change To Inventory(4.2M)9.0M10.3M785K902.8K947.9K
Change In Working Capital242K13.0M8.1M(5.0M)(5.8M)(5.5M)
Stock Based Compensation1.9M3.9M2.2M3.5M4.1M4.3M
Change To Account Receivables1.9M(1.7M)(902K)(1.9M)(1.7M)(1.6M)
Investments(12.1M)8.7M1.1M942K1.1M1.1M
Net Borrowings(3.5M)(4.1M)(5.6M)10.6M12.2M12.9M
Change To Operating Activities(812K)(2.6M)(3.0M)6.8M7.8M8.2M
Change To Netincome5.3M6.9M8.3M7.1M8.1M6.0M
Change To Liabilities6.2M3.4M5.6M(1.1M)(1.0M)(954.2K)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.